Juno Pharmaceuticals

About

Juno Pharmaceuticals develops and commercializes complex, high-value generic and biosimilar products for the Canadian market, employing niche product selection and disciplined pipeline construction across a multinational pharma-device group.

Mission

Juno Pharmaceuticals specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company’s management team has decades of pharmaceutical industry experience and focuses on niche product selection and disciplined pipeline construction. Juno is an early member of the global Juno Pharmaceuticals group, with operations spanning four continents and over 10 pharmaceutical and medical device businesses across Canada, the United Kingdom, the European Union, Australia and South Africa. The company plans to use proceeds from the recent growth equity investment to expand its complex and high-value generic and biosimilar portfolio and to accelerate growth. The announcement did not disclose operating metrics or specific financial terms.

Quick Facts